Skip to content

A study to check the safety and benefits of a hair care routine for reducing hair fall and improving hair growth and thickness

To evaluate in vivo safety and efficacy of hair care regime in terms of hair growth i.e., improvement in A is to T ratio, reduction in hair fall and improvement in hair thickness on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099366
Enrollment
36
Registered
2025-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Regime with VLCL EXOSBNCON774 and VLCL EXOHGSRM775: It is regime with 2 products, Product VLCL EXOSBNCON774 is applied on Whole Head including Scalp and Hair shaft once in 15 days for t

Sponsors

VLCC Personal Care Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian or Asian male & female subjects. 2)Healthy subjects. 3)Skin is healthy on the studied anatomic unit. 4)Having androgenetic alopecia of class I-2 to I-4 according to Ludwig Scale for females and class II to III (including III, IIIA and III vertex) according to Norwood Hamilton Scale for males.

Exclusion criteria

Exclusion criteria: 1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past six months. 2)Having refused to give her assent by not signing the consent form. 3)Taking part in another study is liable to interfere with this study. 4)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area. 5)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Being epileptic 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Having cutaneous hypersensitivity 10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 11)Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 12)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 13)Having changed his/her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit. 14)Having applied a hair care product and cosmetic product on the studied area as well as on the face the first day of the study (except the neutral shampoo without anti-dandruff and anti hairfall claim)

Design outcomes

Primary

MeasureTime frame
Safety and efficacy of hair care regime in terms of hair growth i.e., improvement in anagen telogen ratio, reduction in hair fall and improvement in hair thicknessTimepoint: Baseline,T+30 days, T+60 days, T+75 days, T+90 days, T+120 days

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026